Search Results - "Carmona Echeverria, L."

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS by Norris, J., Carmona Echeverria, L., Bott, S.R.J., Brown, L., Burns-Cox, N., Dudderidge, T.J., El-Shater Bosaily, A., Frangou, E., Freeman, A., Ghei, M., Henderson, A., Hindley, R.G., Kaplan, R.S., Kirkham, A., Oldroyd, R., Parker, C., Persad, R., Punwani, S., Rosario, D.J., Shergill, I.S., Stavrinides, V., Winkler, M., Whitaker, H.C., Ahmed, H.U., Emberton, M.

Get full text

Spatial transcriptomics analysis of co-targeted PIM and PI3 K/mTOR in multikinase inhibitor and single kinase inhibitor combination-treated patient-derived prostate cancer explants by Okoli, U., Akman, G., Thavarajah, V., Carmona Echeverria, L.M., Griffin, J., Ohayi, S.R., Freeman, A., Haider, A., Shaw, G., Sridhar, A.N., Kelly, J., Simpson, B., Pye, H., Crompton, J., Whitaker, H., Cheema, U., Heavey, S.

Get full text

120 Systematic transperineal prostate (TP-B) biopsies – the first prospective evaluation of patient reported complications, symptoms and experience by Wadhwa, K, Carmona-Echeverria, L, Kuru, T.H, Cheng, X, Dimov, I, Serrao, E, Gaziev, G, Seidenader, J.S, Acher, P, Gnanapragasam, V, Muir, G, Hadaschik, B, Kastner, C

Get full text